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†Physikalisch-Technische Bundesanstalt, Berlin, Germany; and ‡Division of Soft Matter Physics, University of Leipzig, Leipzig, GermanyABSTRACT The binding of the MARCKS peptide to the lipid monolayer containing PIP2 increases the lateral pressure of the
monolayer. The unbinding dynamics modulated by protein kinase C leads to oscillations in lateral pressure of lipid monolayers.
These periodic dynamics can be attributed to changes in the crystalline lipid domain size. We have developed a mathematical
model to explain these observations based on the changes in the physical structure of the monolayer by the translocation of
MARCKS peptide. The model indicates that changes in lipid domain size drives these oscillations. The model is extended to
an open system that sustains chemical oscillations.INTRODUCTIONCellular membranes are formed by different types of
proteins dispersed in a lipid bilayer. Proteins and lipids
are not randomly distributed in the membrane but they asso-
ciate according to their hydrophobic and electrical proper-
ties (1). Spatial organization of lipids and proteins in
membranes is still a puzzling problem. Lipid mixtures can
assemble in domainlike, inhomogeneous structures (2),
and self-organization among different proteins processes
can give rise to the formation of traveling waves in lipid
bilayers mimicking the membranes of bacteria (3). There
is an increasing interest for the nonequilibrium self-organi-
zation of spatiotemporal structures in controlled in vitro
experiments to understand similar behavior in living cells.
Phosphatidylinositol 4,5-biphosphate (PIP2) is a phospho-
lipid component of the cell membrane. This phospholipid
performs an important function in membranes for signaling.
Its hydrolysis by phospholipase C generates two second
messengers: inositol 1,4,5-triphosphate and diacylglycerol.
To avoid the onset of the process, PIP2 is sequestered by
myristoylated alanine-rich C kinase substrate (MARCKS)
(4). MARCKS is an unfolded protein that has multiple func-
tions and is related to the regulation of cytoskeletal
dynamics (5), phagocytosis (6), and exocytosis (7). The
effector domain of MARCKS interacts electrostatically
with PIP2, causes the binding of the protein to the membrane
(8), and inhibits the hydrolysis of the phospholipid. The
action of protein kinase C (PKC) reverses this process
because phosphorylated MARCKS no longer binds to
PIP2 in the membranes and diffuses in the cytosol (9).
PKC is activated and translocated to the membrane by
calcium, diacylglycerol, and phospholipids (10). It is also
known that PIP2 enhances the translocation of PKC (11–13).Submitted July 23, 2010, and accepted for publication December 2, 2010.
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constitutes a reaction-diffusion system that allows us
to study the impact of pattern formation on signal transduc-
tion (14–16). Furthermore, PKC oscillations produced by
calcium oscillations have been observed (17) and the
possible interactions and feedbacks on the calcium
dynamics have been discussed (18).
A well-suited method for studying pattern formation
of lipids within an interface is the Langmuir monolayer
technique. In this reduced scheme, the monolayer represents
the inner layer of the membrane and the Langmuir subphase
represents the cell cytosol. The translocations of MARCKS
and PKC between the monolayer and the subphase and the
phosphorylation of MARCKS by PKC in the monolayer
are sketched in Fig. 1. The reduced number of ingredients
in the Langmuir monolayer permits the description of the
observations by a mathematical kinetic model.
Here, we study the binding of MARCKS peptides (con-
sisting on the effector domain of MARCKS proteins)
to monolayers containing PIP2. The interaction among
phospholipids, MARCKS peptides, and PKC produces
a cyclic translocation of the peptides in the monolayer.
We interpret the observations and propose a mechanism
for the oscillations. The mathematical formulation of such
a mechanism as a reaction-diffusion model permits us to
obtain numerical results and facilitates comparison with
the experimental observations. This model can be further
extended to open conditions, where several biological
concentrations are continuously submitted. The extended
model predicts coherent oscillations.MATERIALS AND METHODS
Experiment
To study the interaction between MARCKS and PIP2, we have chosen an
electrostatically neutral lipid as matrix for the charged lipid. According
to the measurements at the air/water interface, saturated lipids with thedoi: 10.1016/j.bpj.2010.12.3702
FIGURE 1 Sketch of the attachment-detachment mechanism of
MARCKS and PKC and of the phosphorylation of MARCKS by PKC.
940 Alonso et al.same lipid chain length are employed to achieve a quite stable configura-
tion. The long size of the lipid chains precludes any perturbation by
Marangoni effects (19). Thus, the monolayer was composed by DPPC
(1,2-dipalmitoyl-sn-glycero-3-phosphocholine) and PIP2 (1,2-dipalmitoyl-
phosphatidylinositol 4,5-diphosphate), both from Sigma-Aldrich (St. Louis,
MO).
The lipid solutions were mixed to the desired PIP2 content before
spreading. The amount of PIP2 in the lipid system was always 10 mol %.
The mixed lipid solution was spread on a subphase, consisting of
100 mM NaCl, 10 mM HEPES, 1 mM CaCl2, and 5 mM adenosine triphos-
phate (to provide the phosphate for phosphorylation by PKC), dissolved in
Millipore water (Billerica, MA), adjusted to pH 7.4. Finally, 0.1 mM
MARCKS (151–175) peptide was added to the subphase. This peptide
sequence, the so-called effector domain, is responsible for the electrostatic
interaction with the membrane interface (4) and substitutes the MARCKS
protein in our experiment. MARCKS (151–175) was obtained as lyophi-
lized powder from AnaSpec (San Jose, CA) and dissolved in Millipore
water.
The measurements are carried out with a homemade film balance and
a KSV Minimicro LB system (Helsinki, Finland). The Minimicro film
balance trough is equipped with a special port for the PKC injection into
the subphase. In this way, we avoid a disruption of the monolayer due to
injection. PKC containing the a-, b-, and g-isotypes was obtained from
Biomol International (Plymouth Meeting, PA).Model
A complete model of the system would contain variables defined in a three-
dimensional subphase as well as variables defined at a two-dimensional
interface. However, the experimental measurements record the lateral
pressure, an integral quantity that depends on the whole monolayer. Due
to the large size of the monolayer (6.25 cm2) and to simplify the model,
we assume that the monolayer is effectively in a spatially homogeneous
state and we neglect the spatial details of the attachment-detachment
processes. Because we neglect spatial changes in the monolayer, we can
restrict the modeling to the computation of one-dimensional profiles along
the z-coordinate describing the direction orthogonal to the membrane plane.
To derive the model, we divide the system into two compartments:
a narrow layer, where all the reactions take place (0<z<‘); and a passive
subphase (‘<z<L), where ‘ is the size of this narrow layer (16) and L the
vertical size of the system. The details of the reaction processes in this
narrow layer will be fixed in the next sections. Three chemical species:
MARCKS peptides (M), PKC enzymes (P), and phosphorylated MARCKS
peptides (MP) diffuse in the subphase (‘<z<L),
vtMðz; tÞ ¼ DMv2zMðz; tÞ;
vtPðz; tÞ ¼ DPv2zPðz; tÞ;
vtMpðz; tÞ ¼ DMv2zMpðz; tÞ;
(1)
where DM and DP are the diffusion coefficients of MARCKS and PKC,
respectively. The values of the diffusion constants are estimated from theBiophysical Journal 100(4) 939–947molecular weight (20). The reactions occur only near the monolayer
(0<z<‘),
vtMðz; tÞ ¼ RM þ DMv2zMðz; tÞ;
vtPðz; tÞ ¼ RP þ DPv2zPðz; tÞ;
vtMpðz; tÞ ¼ RMP þ DMv2zMpðz; tÞ;
(2)
where the terms Ri correspond to the nonlinear reaction rates and attach-
ment-detachment processes and in general may depend on the MARCKS
and PKC concentrations in the subphase and at the monolayer, and on
the state of the monolayer (see below).
Formally, we may define the concentration of monolayer-bound proteins
as
vt ~mðz; tÞ ¼ RM  RMP þ D~mV2 ~mðz; tÞ:
We neglect the structure in the narrow layer near the membrane and
define the average
mðtÞ ¼ ð1=‘Þ
Z‘
0
~mðz; tÞdz:
The contribution of the diffusion is zero and we approximate the reaction
rates with
ð1=‘Þ
Z‘
0
Ridzzð1=‘ÞRi‘ ¼ Ri;
which leads to Eq. 3. Equivalent arguments can be used to obtain equations
for the average quantities p(t) and q(t).
The corresponding equations for the averaged concentration of
MARCKS peptides (m) and PKC enzymes (p) at the monolayer are
obtained from an approximation and read
_mðtÞ ¼ RM  RMP; (3)
_pðtÞ ¼ RP: (4)
To model the interaction between the monolayer and the subphase, we
consider a narrow layer from which proteins bind and into which proteins
are released from the monolayer. This layer is diffusively coupled to the
subphase.
We define the integral quantities
fM ¼ L1
ZL
0
Mdz and fMp ¼ L1
ZL
0
Mpdz;
which represent the total amount of free and phosphorylated MARCKS
peptides in the subphase, respectively. Equivalently we define the total
amount of PKC in the subphase as
fP ¼ L1
ZL
0
Pdz:
The total amount of peptides
fM;T ¼ mþ fM
and of enzymes
fP;T ¼ pþ fP
are conserved quantities, and hence are fixed parameters in the model.
Finally, we also need to consider a variable q to account for the structure
of the monolayer. The value of q is related with the accessible quantity of
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structure upon binding of the peptides, which in turn affects the attachment
rates of the peptides. We use a simple phenomenological equation to
describe the dependence of the variable q on the monolayer-bound
MARCKS:
_qðtÞ ¼ Rq: (5)
We employ a finite difference method in one dimension to perform
numerical simulations of the diffusion of the species. For the boundaries
of our one-dimensional model system (bottom and top of the container),
we impose no-flux conditions. The size of the narrow layer in the numerical
simulations is small and we choose ‘ ¼ Dz to avoid any type of structure
near the monolayer. The total amount of peptides is kept constant. It is fixed
by the initial condition.FIGURE 2 Increase of lateral pressure in the compressed monolayer due
to attachment of MARCKS peptide.
FIGURE 3 Fluorescence micrographs of (a) the initial state and (b) after
attachment of MARCKS at the monolayer (24).RESULTS
Translocation of MARCKS
Experiments
First, we perform experiments without the introduction of
PKC in two different versions. Either the monolayer of
the lipid mixture is compressed from a null lateral pressure
to 10 mN/m 5 0.5 mN/m or the lipid mixture is spread on
an initial pressure of 20 mN/m5 0.5 mN/m. A difference in
the size of the liquid condensed lipid domains is observed
depending on the manner of preparation. The ordered lipid
domains in a slowly compressed monolayer are larger and
better developed with respect to a monolayer, and directly
spread out on a certain pressure.
We probe both variants to exclude a dependency on the
lateral organization of the monolayer. At a lateral pressure
of 10 mN/m, the monolayer is already above the main phase
transition in a liquid condensed state with remnants of disor-
dered loosely packed regions, and the interaction between
MARCKS peptide and the monolayer can still be visualized
by fluorescence microscopy. Above 10 mN/m, the dye
distribution disappears with increase in lateral pressure
and a visual observation is no longer possible. Nevertheless,
the remnants of disordered phase are preserved (22). Here,
the interaction can be only recorded indirectly through
lateral pressure measurements.
Initially, there is an homogeneous distribution of the
MARCKS peptide in the subphase, because of its good solu-
bility in water. Control experiments do not show any activity
of the peptide at the bare buffer/air interface. When the
monolayer is prepared on the subphase, the peptide begins
to translocate to the monolayer. Attachment of MARCKS
peptide to the monolayer causes the lateral pressure to
increase monotonically due to a partial penetration of the
peptide into the monolayer (23,24). This increase of the
lateral pressure is effectively only caused by the effector
domain of MARCKS.
Experiments with EDTA in the subphase instead of CaCl2
have shown a very similar behavior. In both experiments, the
increase of the lateral pressure is completely the same—nodependence on the lateral organization is detectable. We
assume the lateral pressure is proportional to the concentra-
tion of MARCKS peptide attached to the monolayer. The
increase of the lateral pressure ends with the peptide satura-
tion of the monolayer (see Fig. 2). This process is slow and
governed by a diffusion-limited attachment to the mono-
layer. The characteristic diffusion time of the peptide
through the subphase to the monolayer is estimated to be
approximately hours because of an L ¼ 5 mm subphase
thickness. The saturated monolayer remains stable over
a long period of time (see inset in Fig. 2) and only slight
fluctuations are observed.
The attachment of the MARCKS peptide to the mono-
layer produces also a change in the monolayer structure.
The lipid mixture builds a monolayer, formed by solid
DPPC domains surrounded by liquid domains rich in PIP2
(23). The lateral organization of the monolayer will depend
on the presence of bound peptide at the monolayer and will
continuously change with the attachment of peptide. In
Fig. 3, in two different experimental images corresponding
to the structure of the compressed monolayer is shown
the difference between the monolayer without and withBiophysical Journal 100(4) 939–947
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FIGURE 4 Temporal evolution ofm (solid line) and q (dashed line) at the
monolayer (a), and of the fractions fM (solid line) in the subphase (b)
during a numerical simulation. Parameters of the numerical simulations:
DM ¼ 160 mm2/s, kþm ¼ 1 s1, K1 ¼ 1, km ¼ 2  105 s1, and
fM,T ¼ 3.
942 Alonso et al.MARCKS peptide, corresponding to Fig. 3, a and b, respec-
tively. The presence of MARCKS peptide at the monolayer
causes larger solid domains and simultaneously larger areas
of liquid domains. This is explained by the enrichment of
PIP2 in the disordered phase, whereby the interaction with
MARCKS peptide consequently occurs in this phase. The
images, shown in Fig. 3, correspond to a lateral pressure
of p ¼ 15 mN/m. However, regions of disordered phase
persist at higher lateral pressure (23).
The final pressure of the monolayer depends on the initial
concentration of MARCKS peptide in the subphase. The
change of the pressure is small for low concentrations but
it saturates for larger concentrations. For initial concentra-
tions above 25 nM, the final lateral pressure of the mono-
layer is always around the same value. This concentration
defines the monolayer saturation concentration.
Model
Corresponding to the experimental setup, we consider
a closed system with an initial condition far from equilib-
rium. Such an initial condition drives a transient dynamics
of the system approaching an equilibrium state after suffi-
ciently long time. The peptides diffuse through the
subphase. They translocate to the monolayer and from the
monolayer to the subphase near the monolayer. The concen-
tration M of the peptide in the subphase is described by
vtMðz; tÞ ¼ DMv2zMðz; tÞ: (6)
The equations describing translocation dynamics of the
peptide close to the monolayer reads
vtMðz; tÞ ¼ ½1 mðtÞkþmðqÞMðz; tÞ þ kmmðtÞ
þ DMv2zMðz; tÞ; (7)
and the corresponding equations at the monolayer,
_mðtÞ ¼ ½1 mðtÞkþm ðqÞMðz; tÞ  kmmðtÞ;
_qðtÞ ¼ kq½mðtÞ  qðtÞ;
(8)
where the variables M and m correspond to the fractions of
MARCKS in the subphase and the fraction of MARCKS
bound to the monolayer, respectively. The attachment and
detachment of the peptide to the monolayer is accounted
by kþm ðqÞ and km ðqÞ:
The variable m is a nondimensional quantity (0 < m < 1)
describing the coverage of MARCKS on the lipid mono-
layer, where m ¼ 1 corresponds to maximum coverage.
The term (1  m) precludes the attachment of peptides after
the saturation of the monolayer. The variable M is a nondi-
mensional quantity obtained from the renormalization by
the volume saturation concentration of MARCKS. We recall
that the quantity
fM ¼ L1
ZL
0
MdzBiophysical Journal 100(4) 939–947is the total amount of MARCKS peptides in the subphase
divided by the monolayer saturation value.
The variable q corresponds to the state of the monolayer
(i.e., q ¼ 0 corresponds to small domains as in Fig. 3 a and
q ¼ 1 to large domains; see in Fig. 3 b) and its phenomeno-
logical equation tries to describe the change of the domain
size and the properties of the monolayer with the binding
of MARCKS.
The function kþm ðqÞ is nonlinear, and accounts for the
dependence of the attachment rate of MARCKS on the state
of the monolayer (q). The explicit forms of the function em-
ployed here is a Hill function
kþm ðqÞ ¼ kþmq2=

q2 þ K21

:
If kq is large, we can adiabatically eliminate this variable
using q ¼ m in the function kþm ðqÞ and obtain finally a Hill
function of the concentration m. A similar dependence on
the concentration has been previously observed in experi-
ments of binding of MARCKS to vesicles (25).
Simulations
We integrate Eqs. 6–8 to study the dynamics of MARCKS
peptides interacting with the monolayer. Based on an
initially homogeneous distribution M of MARCKS in the
subphase, there is a monotonous increase of the concentra-
tion of monolayer-bound peptidesm (see Fig. 4 a). It implies
an increase of the monolayer pressure due to the binding of
MARCKS because the lateral pressure is assumed to be
proportional to m. The translocation to the monolayer
produces a decrease of concentration in the subphase region
near the membrane. This, in turn, induces a concentration
gradient of free peptide in the subphase, which induces
the transport of more peptide to the monolayer. If the system
remains undisturbed, the peptide accumulates at the mono-
layer until saturation is reached (see Fig. 4). The simulation
Oscillations in the Lateral Pressure 943reproduces the results observed in the experiments shown in
Fig. 2. Both curves exhibit similar times (~3 h) for reaching
half of the saturation pressure respective to concentration.
The total quantity of peptide is kept constant during the
simulation. It implies that the increase on the concentration
of monolayer-bound proteins (m) produces a reduction on
the concentration of MARCKS in the subphase (fM) (see
Fig. 4 b).Phosphorylation of MARCKS by PKC
Model
The enzyme PKC diffuses in the cytosol, and phosphory-
lates membrane-bound MARCKS proteins in living cells
(4). To study this process, we consider the effects of the
introduction of PKC into the system. This enzyme has
binding affinity to the monolayer where it becomes active
(10). We assume an attachment-detachment process for
the PKC similar to the one previously considered for
MARCKS. The equations describing the mentioned
processes are
vtPðz; tÞ ¼ DPv2zPðz; tÞ; (9)
for the diffusion of PKC in the subphase,
vtPðz; tÞ ¼  ½1 mðtÞ½1 pðtÞkþp ðqÞPðz; tÞ
þ kp pðtÞ þ DPv2z Pðz; tÞ;
(10)
for the reactions close to the monolayer and at the mono-
layer, and
_pðtÞ ¼ ½1 mðtÞ½1 pðtÞkþp ðqÞPðz; tÞ  kp pðtÞ; (11)
where the variable p is a nondimensional quantity (0 < p <
1) describing the coverage of PKC on the lipid monolayer
and p ¼ 1 corresponds to maximum coverage. The variable
P is a nondimensional quantity obtained from a scaling of
the physical concentration of PKC by a volume saturation
concentration of PKC. The function kþp ðqÞ is nonlinear,
and accounts for the dependence of the attachment rate of
PKC on the state of the monolayer (q), that is related to
the available phospholipid concentration. The explicit
form employed here is a Hill function
kþp ðqÞ ¼ kþp qn=

qn þ Kn2

with a large Hill coefficient n¼ 8. A similar dependence has
been previously observed for PKC attachment to phospho-
lipids (25,26).
The activation of PKC leads to the phosphorylation of
MARCKS peptides. To account for this additional translo-
cation process, an additional term in the dynamics of the
MARCKS peptide in the membrane is employed and the
model equations have to be supplemented by additional
equations for the concentration of phosphorylatedMARCKS peptides Mp. The diffusion of phosphorylated
MARCKS peptides in the subphase is described by
vtMpðz; tÞ ¼ DMv2zMpðz; tÞ: (12)
The PKC-induced translocation and phosphorylation of
MARCKS follows the rate equations
vtMpðz; tÞ ¼ kmðtÞpðtÞ þ DMv2zMpðz; tÞ (13)
close to the monolayer and
_mðtÞ ¼ ½1 mðtÞkþm ðqÞMðz; tÞ  kmmðtÞ  kmðtÞpðtÞ (14)
at the monolayer. The variableMp is a nondimensional quan-
tity obtained from the rescaling of the concentration of phos-
phorylated MARCKS peptides by the volume saturation
concentration. The phosphorylation process requires the
presence of adenosine triphosphate, which is assumed to
have a constant concentration and to be homogeneously
distributed during the whole process. (Note that kinetic
parameters of the equations are given in the caption of
Fig. 4.) The final set of equations of the model reads
vtMðz; tÞ ¼ DMv2zMðz; tÞ;
vtPðz; tÞ ¼ DPv2zPðz; tÞ;
vtMpðz; tÞ ¼ DMv2zMpðz; tÞ;
(15)
for the diffusion processes in the subphase (‘<z<L),
vtMðz; tÞ ¼ ½1 mðtÞkþmðqÞMðz; tÞ þ kmmðtÞ
þDMv2zMðz; tÞ;
vtPðz; tÞ ¼ ½1 mðtÞ½1 pðtÞkþp ðqÞPðz; tÞ
þkp pðtÞ þ DPv2zPðz; tÞ;
vtMpðz; tÞ ¼ kmðtÞpðtÞ þ DMv2zMpðz; tÞ;
(16)
close to the monolayer (0<z<‘) and
_mðtÞ ¼ ½1 mðtÞkþmðqÞMðz; tÞkmmðtÞkmðtÞpðtÞ;
_pðtÞ ¼ ½1 mðtÞð1 pðtÞÞkþp ðqÞPðz; tÞ  kp pðtÞ;
_qðtÞ ¼ kq½mðtÞ  qðtÞ;
(17)
at the monolayer. Capital letters describe the concentration
in the subphase. This set of equations accounts for the
binding dynamics of MARCKS peptide and PKC and the
interaction between them.
Simulations
Fig. 5 shows the evolution of the corresponding quantities of
the model when the equations are solved numerically.
Initially, the concentration of monolayer-bound MARCKS
peptide grows with time. However, if PKC is introduced,
there are damped oscillations in the monolayer (Fig. 5 a).
PKC is introduced with a strongly localized concentration
distribution inside the subphase and close to the monolayer.Biophysical Journal 100(4) 939–947
FIGURE 6 Three different experiments showing the oscillations in lateral
pressure in the monolayer after introduction of PKC. (Top) Home-made film
balance, monolayer spread-out on an initial pressure of 20 mN/m. (Middle
and bottom) Two realizations of monolayer compressed up to 9 mN/m.
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FIGURE 5 Temporal evolution of m (dark line), p (line), and q (dashed
line) at the monolayer (a), and of the fractions fM (solid line) and fMp
(dashed line) in the subphase (b) during a numerical simulation. (Arrow)
Moment of the introduction of PKC. Parameters of the numerical simula-
tions: DM ¼ 160 mm2/s, DP ¼ 60 mm2/s, kþm ¼ 1 s1, km ¼ 2  105
s1, kþp ¼ 0.2 s1, kp ¼ 2  104 s1, k ¼ 2  102 s1, kq ¼ 0.0005
s1, K1 ¼ 1, K2 ¼ 0.25, n ¼ 8, fM,T ¼ 3, and fP,T ¼ 0.1.
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the simulation. The enzyme drastically reduces the concen-
tration of attached MARCKS at the monolayer, due to the
phosphorylation of the peptide. This detachment of
MARCKS is visible in the decrease of the lateral pressure
of the monolayer.
After this initial reduction, a damped oscillatory behavior
of the lateral pressure in the monolayer is observed. The
amplitude of the pressure oscillation decreases after some
cycles because the reservoir of available unphosphorylated
peptide is depleted at any time and the phosphorylated
peptide remains in the subphase. There are damped oscilla-
tions in the monolayer (Fig. 5 a) accompanied by a decrease
and an increase of fM and fMp, respectively (Fig. 5 b).
In Fig. 5, we employ a specific set of parameter values.
The oscillations are, however, robust for a wide range of
parameter values (results not shown). The period of oscilla-
tions induced by PKC is related to the detachment rate
of PKC.
Experiments
Experiments with PKC were performed and oscillations
have been observed. First, the mixed lipid monolayer was
spread on an initial pressure of 20 mN/m 5 0.5 mN/m
and after the monotonous increase of the lateral pressure
due to the attachment of peptide, a saturation of the mono-
layer is achieved, detected by an achievement of a quite
constant lateral pressure (comparable to Fig. 2). The enzyme
PKC was injected through the monolayer into the subphase
by a syringe. The injection of PKC immediately generates
a decrease in lateral pressure up to the initial pressure
(results not shown). Here we assumed that the inoculation
of PKC has disturbed the interface by causing a convectionBiophysical Journal 100(4) 939–947of the fluid phase. Despite this disturbance, the lateral pres-
sure increases again and oscillations have been observed
over a period of hours.
The experiment was repeated with a different experi-
mental procedure. Hereby, the monolayer was continuously
compressed over the main phase transition range and
stopped at a lateral pressure of p ¼ 10 mN/m. After the
peptide saturation of the monolayer, the PKC injection
occurs by an injection port into the subphase, which avoids
a disturbance of the monolayer. The decrease of the lateral
pressure due to PKC injection could be reproduced. Next,
the lateral pressure increases again and the observed oscilla-
tions of the foregoing experiment could be readily repro-
duced (see Fig. 6).
We have investigated monolayers at two different initial
lateral pressures. The reproducibility of the observed oscilla-
tions of the lateral pressure with different experimental initial
conditions shows that this process is quite robust.
The oscillations of the lateral pressure are interpreted as
oscillations in the concentration of MARCKS peptide bound
to the monolayer. Hereby, the amount of 0.1 mMMARCKS
peptide in the subphase acts as a source for supply of un-
phosphorylated peptide. The characteristic period of the
oscillations is in a range of 3–4 h.
Mechanism of the oscillation
Oscillations are clear indications of nonlinear phenomena.
The nonlinearities of the model are associated to the binding
and unbinding dynamics of peptides and enzymes. These
dynamics depend on the quantity of available PIP2 in the
monolayer. We assume here that the characteristic size of
the disordered phase channels between the ordered domains
in the monolayer depends on the quantity of PIP2 (see
Fig. 3). The binding of MARCKS peptide changes the
Oscillations in the Lateral Pressure 945structure of the monolayer and we assume that it increases
the binding rates of the peptides and the PKC enzymes.
The integration of PIP2 into the DPPC monolayer yields
a phase separation to an ordered condensed DPPC phase
and a disordered fluid PIP2-rich phase (see Fig. 3 and the
sketch in Fig. 7 a). The interaction of MARCKS peptides
with the PIP2 leads to lipid/peptide clusters in the disordered
phase, which causes an increase of the space between the
ordered domains (23). This increase can be observed by
comparison between the experimental images of the mono-
layers without and with attached MARCKS peptide (shown
in Fig. 3, a and b). These two images correspond, respec-
tively, to low and high values of q in our model. The expan-
sion of the disordered phase due to the presence of
MARCKS is sketched in Fig. 7 b. The attachment of PKC
at the interface phosphorylates the peptide (see Fig. 7 c)
and translocates MARCKS from the monolayer into the
subphase (see Fig. 7 d). This detachment of peptides reduces
the space between the ordered lipid domains and releases
PKC from the monolayer (Fig. 7 a); the initial situation is
then recovered.
Model for open system
We have so far considered a closed system where the
process of phosphorylation depletes the resources of
MARCKS in the system. Living cells are open systems,
which may regulate the phosphorylation of MARCKS by
PKC by the following dephosphorylation of MARCKS by
phosphatases (15,27). Hence, we can model an open system
where the peptides can be supplied or removed and the
subphase acts as a reservoir of a constant amounts of
MARCKS and PKC. In such conditions, the concentration
of MARCKS and PKC in the subphase is kept at constant
values, M0 and P0, respectively. Hence, the expressions in
Eq. 17 reduces to the formFIGURE 7 Sketch of the mechanism of lateral pressure oscillations in the
monolayer. Dark-shaded areas represent the solid phase and the light-
shaded channels represent the fluid phase of the monolayer. (a) Initial state
of the monolayer, (b) attachment of MARCKS and increase of the size of
the channels between solid domains, (c) attachment of PKC, and (d) detach-
ment of MARCKS, reduction of the channels, and translocation of PKC._mðtÞ ¼ kþm ðqÞ½1 mðtÞM0  kmmðtÞ  kmðtÞpðtÞ;
_pðtÞ ¼ kþðqÞ½1 mðtÞ½1 pðtÞP  kpðtÞ;p 0 p
_qðtÞ ¼ kq½mðtÞ  qðtÞ:
(18)
Constant M0 requires a continuous addition of peptides
either from synthesis or external input from the outside.
Alternatively, phosphatase can provide recycling of phos-
phorylated MARCKS peptides. This set of equations repre-
sents an open system far from thermodynamic equilibrium,
which gives rise constant amplitude oscillations (Fig. 8),
analogous to chemical systems maintained outside the equi-
librium (28). The possibility to study such oscillations can
help us to clarify the dynamics of processes involving small
sets of reactants.DISCUSSION
A better quantitative understanding of the myristoyl-electro-
static switch described in Thelen et al. (27) for living cells is
the motivation of this work. The realization of well-
controlled experiments is difficult in vivo. Here, we have
built a reduced model system by the change of the cellular
membrane, cytoplasm, and MARCKS proteins by a mono-
layer, a subphase, and MARCKS peptides, respectively.
We keep two steps of the myristoyl-electrostatic switch—
the binding of the protein to the membrane and the phos-
phorylation of the protein. We replace the last part of the
cycle, the dephosphorylation done by phosphatases, by
a reservoir of MARCKS peptide in the subphase.
Here, we have considered a simple phenomenologic
model that predicts the oscillation of the lateral pressure
of the monolayer. Such predictions are confirmed with
experiments. We have developed a model starting from
a reduced number of parameters and a particular choice of
the nonlinear functions based on general arguments. Further
experimental studies will be devoted to the complete charac-
terization of the processes included in the model.0 10 20 30 40
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FIGURE 8 Temporal evolution of m (solid line in a), p (b), and q (dashed
line in a), in the monolayer under nonequilibrium conditions during
a numerical simulation. Same parameters of the numerical simulations as
in Fig. 5 with k ¼ 0.2 s, M0 ¼ 1, and P0 ¼ 1.
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ical membranes. We have considered molecules and
enzymes highly present in cells. The process of control of
monolayers by the enzymes studied here is relevant for
real cellular membranes, because the same ingredients are
present in live cells.
The slow increase of the lateral pressure due to the
attachment of MARCKS peptide at the monolayer can be
reproduced by considering the diffusion of the peptide
through the subphase and a simple binding dynamics to
the monolayer. This process and results of experiments
from the literature have been employed for the estimation
of the parameters in the model.
The introduction of PKC produces a cyclic change in the
monolayer. PKC induces the detachment of MARCKS from
the monolayer into the subphase by phosphorylation. The
posterior detachment of PKC facilitates the attachment of
new MARCKS peptide at the monolayer and the repetition
of the cycle. This type of interaction, combined with trans-
port processes (diffusion), may help us to understand
temporal and spatial aspects on cell signaling.
The damped pressure oscillations after the initial detach-
ment are evidence of nonlinear interactions because kinetic
oscillations are a typical signature of nonlinear processes.
The model presented here shows that the feedback provided
by the nonlinear binding rates of peptides and enzymes to
the monolayer and the coupling of the monolayer’s structure
with the peptide concentration are the most important ingre-
dients for the oscillations.
We have predicted oscillations with large temporal
periods by numerical simulations and simple experiments
in monolayers. The period of the oscillations mainly
depends on the dynamics of the domains and fluid channels,
which in our model is determined by the rate kq. Cellular
membranes are heterogeneous and are formed by different
domains. The extrapolation of our results to living cells
has to take into account the possible differences of domain
structure and dynamics. However, low frequency oscilla-
tions may help to regulate some of the processes controlled
by the cellular membrane. Although many cellular clocks
involve gene expression, the here-observed simple chemical
oscillations may serve as a local clock within the cell
membrane. In this article, we present an alternative mecha-
nism for the timing of biological processes based on cyclic
binding and unbinding of MARCKS proteins at biological
membranes.
In summary, nonlinear interactions among peptides,
enzymes, and the configuration of a monolayer produce
a cyclic translocation of peptides and enzymes in the mono-
layer in a simple experimental setup that leads to periodic
changes of the lateral pressure in the monolayer on a time-
scale of several hours. The oscillations are reproduced by
a reaction-diffusion model by the introduction of nonlinear
rates depending on the state of the monolayer. This model
can be extended to conditions outside of thermodynamicBiophysical Journal 100(4) 939–947equilibrium where continuous oscillations are found in
simulations.
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